Neuland Laboratories Limited (BOM:524558)

Neuland Laboratories Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	13,300	14,768	15,586	11,912	9,511	9,369
Other Revenue	-	-	-	2.88	5.99	0.56
Revenue	13,300	14,768	15,586	11,915	9,517	9,370
Revenue Growth (YoY)	-18.67%	-5.24%	30.81%	25.20%	1.57%	22.64%
Cost of Revenue	6,904	7,505	7,338	6,138	5,535	5,547
Gross Profit	6,396	7,263	8,248	5,777	3,982	3,823
Selling, General & Admin	2,737	2,734	2,580	2,026	1,832	1,505
Other Operating Expenses	1,242	1,224	1,038	917.43	698.58	824.83
Operating Expenses	4,674	4,613	4,214	3,471	3,021	2,726
Operating Income	1,722	2,650	4,033	2,306	960.9	1,096
Interest Expense	-77.04	-57.89	-110.74	-104.02	-95.34	-128.01
Interest & Investment Income	105.84	105.84	82.27	15.56	9.95	16.68
Currency Exchange Gain (Loss)	5.96	5.96	-0.55	-103.33	-1.02	-21.67
Other Non Operating Income (Expenses)	5.41	-25.08	-29.23	-21.45	-34.79	-38.19
EBT Excluding Unusual Items	1,763	2,679	3,975	2,092	839.71	925.14
Gain (Loss) on Sale of Investments	76.83	76.83	-	-	-	-
Gain (Loss) on Sale of Assets	-73.11	-73.11	-4.02	-8.71	-18.08	128.19
Other Unusual Items	573.32	779.58	40.36	37.85	-	-
Pretax Income	2,341	3,463	4,014	2,157	821.63	1,053
Income Tax Expense	579.22	862.21	1,014	522.29	183.41	247.03
Earnings From Continuing Operations	1,761	2,601	3,001	1,635	638.22	806.31
Net Income	1,761	2,601	3,001	1,635	638.22	806.31
Net Income to Common	1,761	2,601	3,001	1,635	638.22	806.31
Net Income Growth	-47.59%	-13.32%	83.52%	156.21%	-20.85%	397.40%
Shares Outstanding (Basic)	13	13	13	13	13	13
Shares Outstanding (Diluted)	13	13	13	13	13	13
Shares Change (YoY)	0.01%	-	-	-	-	-
EPS (Basic)	137.27	202.74	233.89	127.45	49.74	62.85
EPS (Diluted)	137.27	202.74	233.89	127.45	49.74	62.85
EPS Growth	-47.59%	-13.32%	83.52%	156.23%	-20.85%	397.59%
Free Cash Flow	-	1,109	1,175	1,711	-372.97	839.65
Free Cash Flow Per Share	-	86.45	91.59	133.35	-29.07	65.44
Dividend Per Share	-	12.000	14.000	10.000	5.000	5.000
Dividend Growth	-	-14.29%	40.00%	100.00%	-	150.00%
Gross Margin	48.09%	49.18%	52.92%	48.49%	41.84%	40.80%
Operating Margin	12.95%	17.95%	25.88%	19.35%	10.10%	11.70%
Profit Margin	13.24%	17.61%	19.25%	13.72%	6.71%	8.61%
Free Cash Flow Margin	-	7.51%	7.54%	14.36%	-3.92%	8.96%
EBITDA	2,325	3,243	4,588	2,792	1,404	1,449
EBITDA Margin	17.48%	21.96%	29.44%	23.43%	14.75%	15.47%
D&A For EBITDA	602.76	593.07	554.31	486.2	443.13	352.88
EBIT	1,722	2,650	4,033	2,306	960.9	1,096
EBIT Margin	12.95%	17.95%	25.88%	19.35%	10.10%	11.70%
Effective Tax Rate	24.75%	24.90%	25.25%	24.21%	22.32%	23.45%
Revenue as Reported	13,535	14,973	15,711	12,009	9,532	9,530

Source: S&P Global Market Intelligence. Standard template. Financial Sources.